Eziclen concentrate for oral solution

Eziclen is a prescription pharmaceutical product used for bowel cleansing prior to medical procedures such as colonoscopies. It is a concentrated oral solution composed of sodium sulfate, magnesium sulfate, and potassium sulfate. This specific medication is widely used in Europe and is known for its osmotic properties that facilitate effective gastrointestinal preparation.

The brand was originally developed by the French pharmaceutical group Laboratoires Mayoly Spindler. Founded as a family-owned laboratory, the company has grown into a significant international player in the health sector, with a strong focus on gastroenterology. In 2023, a major transformation occurred when Mayoly Spindler acquired Ipsen's Consumer Healthcare business, leading to the creation of the unified entity 'Mayoly'. The brand remains under French ownership, maintaining its headquarters and primary manufacturing facilities in France to ensure strict pharmaceutical quality standards.